Cite

HARVARD Citation

    Stratigos, A. et al. (2021). Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial. Lancet oncology. 22 (6), pp. 848-857. [Online]. 
  
Back to record